eTOX Final Meeting took place in Basel (Switzerland) on November 2016.
eTOX Newsletter has been launched
Welcome to the eTOX Website
The eTOX project aims to develop a drug safety database from the pharmaceutical industry legacy toxicology reports and public toxicology data; innovative in silico strategies and novel software tools to better predict the toxicological profiles of small molecules in early stages of the drug development pipeline
eTOX launches a video presenting the 2nd hackathon event held at the PRBB, which also gives an insight into the project.
eTOX Final Consortium Meeting - Pierre Meulien Keynote
eTOX Final Consortium Meeting was held in Basel (Switzerland) on the 29th of November 2016. Pierre Meulien, IMI Executive Director, gave a Keynote with the title: Current strategies and implementation of the IMI-2 programme.
eTOX, under Grant Agreement nš115002, is funded by the Innovative Medicines Initiative Joint Undertaking (IMI-JU), a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
eTOX Project extension (ENSO) has been approved by IMI .
See more details here.